J Rheum Dis.  2025 Jan;32(1):57-62. 10.4078/jrd.2024.0030.

Juvenile lupus-like with negative serology: a clinical dilemma and diagnostic challenge

Affiliations
  • 1Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
  • 2Pediatric Rheumatology, Department of Pediatric, Pediatric Hospital, King Saud Medical City, Riyadh, Saudi Arabia
  • 3Pediatric Nephrology, Department of Pediatric, Pediatric Hospital, King Saud Medical City, Riyadh, Saudi Arabia
  • 4Pediatric Nephrology, 5 Pediatric Rheumatology, Department of Pediatrics, Faculty of Medicine, King Abdulaziz University, Jeddah, Saudi Arabia
  • 5Immunology Unit, King Fahad Medical Research Center, King Abdulaziz University, Jeddah, Saudi Arabia

Abstract

Systemic lupus erythematosus (SLE) is an autoimmune disorder that can affect various organs. Juvenile-onset SLE (jSLE) may be more severe than the adult-onset form, but the diagnosis and classification remain challenging due to the complex nature of the condition and its resemblance to other conditions. Antinuclear antibodies (ANA) are the immunological hallmark of SLE, but their limited specificity poses challenges. The 2019 (European Alliance of Associations for Rheumatology/American College of Rheumatology) SLE proposed a weighted multi-criteria system for classifying SLE, with ANA serving as an entry criterion. However, seronegative SLE, in which a patient's clinical features and laboratory values are consistent with SLE but their ANA serology test is negative, is a rare subtype of SLE that has been reported in several cases worldwide. Here, we present two rare cases of jSLE in 13- and 11 years old girls with negative ANA. The first case presented as lupus cerebritis and lupus nephritis (LN) class IV and V which showed improvement with treatment. The other one was also diagnosed as LN class IV but showed poor outcome despite aggressive immunosuppressive treatment. These cases highlight the importance of considering lupus-like symptoms in children with negative serology and the need for further research into current diagnostic protocols and calls for a re-evaluation using a more inclusive set of criteria that does not centralize immunological serology.

Keyword

Lupus-like; Systemic lupus erythematosus; Antinuclear antibodies negative; Seronegative

Reference

1. Smith EMD, Lythgoe H, Midgley A, Beresford MW, Hedrich CM. 2019; Juvenile-onset systemic lupus erythematosus: update on clinical presentation, pathophysiology and treatment options. Clin Immunol. 209:108274. DOI: 10.1016/j.clim.2019.108274. PMID: 31678365.
2. Brunner HI, Gladman DD, Ibañez D, Urowitz MD, Silverman ED. 2008; Difference in disease features between childhood-onset and adult-onset systemic lupus erythematosus. Arthritis Rheum. 58:556–62. DOI: 10.1002/art.23204. PMID: 18240232.
3. Bertsias GK, Pamfil C, Fanouriakis A, Boumpas DT. 2013; Diagnostic criteria for systemic lupus erythematosus: has the time come? Nat Rev Rheumatol. 9:687–94. DOI: 10.1038/nrrheum.2013.103. PMID: 23838616.
4. Slater CA, Davis RB, Shmerling RH. 1996; Antinuclear antibody testing. A study of clinical utility. Arch Intern Med. 156:1421–5. DOI: 10.1001/archinte.1996.00440120079007. PMID: 8678710.
5. Khan QA, Khan T, Abdi P, Farkouh C, Anthony M, Hadi FA, et al. 2023; Diagnostic dilemma of ANA-negative pediatric systemic lupus erythematosus in a South Asian female. Clin Med Insights Case Rep. 16:11795476231174321. DOI: 10.1177/11795476231174321. PMID: 37205006. PMCID: PMC10186573.
6. Wen YK, Chen ML. 2010; Clinicopathological study of originally non-lupus "full-house" nephropathy. Ren Fail. 32:1025–30. DOI: 10.3109/0886022X.2010.510614. PMID: 20863204.
7. Sharman A, Furness P, Feehally J. 2004; Distinguishing C1q nephropathy from lupus nephritis. Nephrol Dial Transplant. 19:1420–6. DOI: 10.1093/ndt/gfh139. PMID: 15004260.
8. Enriquez JL, Rajaraman S, Kalia A, Brouhard BH, Travis LB. 1988-1989; Isolated antinuclear antibody-negative lupus nephropathy in young children. Child Nephrol Urol. 9:340–6.
9. Cairns SA, Acheson EJ, Corbett CL, Dosa S, Mallick NP, Lawler W, et al. 1979; The delayed appearance of an antinuclear factor and the diagnosis of systemic lupus erythematosus in glomerulonephritis. Postgrad Med J. 55:723–7. DOI: 10.1136/pgmj.55.648.723. PMID: 317153. PMCID: PMC2425745.
10. Gianviti A, Barsotti P, Barbera V, Faraggiana T, Rizzoni G. 1999; Delayed onset of systemic lupus erythematosus in patients with "full-house" nephropathy. Pediatr Nephrol. 13:683–7. DOI: 10.1007/s004670050681. PMID: 10502127.
11. Hunley TE, Yared A, Fogo A, MacDonell RC Jr. 1998; Nephrotic syndrome in an adolescent: the cry of the wolf. Am J Kidney Dis. 31:155–60. DOI: 10.1053/ajkd.1998.v31.pm9428468. PMID: 9428468.
12. Gomathy S, Samuel U, Arun KA, Pradeep B. 2017; Non lupus full house nephropathy - a clinical and pathological correlation study. IOSR J Dent Med Sci. 16:69–76. DOI: 10.9790/0853-1603076976.
13. Maziad ASA, Torrealba J, Seikaly MG, Hassler JR, Hendricks AR. 2017; Renal-limited "lupus-like" nephritis: how much of a lupus? Case Rep Nephrol Dial. 7:43–8. DOI: 10.1159/000475493. PMID: 28612005. PMCID: PMC5465519.
14. Ahmed M, Love T, Moore C, Le TH, Jean-Gilles J, Goldman B, et al. 2022; The spectrum of renal diseases with lupus-like features: a single-center study. Ren Fail. 44:581–93. DOI: 10.1080/0886022X.2022.2057862. PMID: 35357272. PMCID: PMC8979540.
Full Text Links
  • JRD
Actions
Cited
CITED
export Copy
Close
Share
  • Twitter
  • Facebook
Similar articles
Copyright © 2025 by Korean Association of Medical Journal Editors. All rights reserved.     E-mail: koreamed@kamje.or.kr